What to Know About Heart Failure When You Have Diabetes
In June of 2022, a report from the American Diabetes Association highlighted heart failure as “an underappreciated complication of diabetes.” According to that report, up to 22% of people with diabetes will develop heart failure, and the incidence of heart failure within the diabetes community is increasing. “Heart failure is the most prevalent cardiovascular complication in people with diabetes,” says Dr. Rodica Pop-Busui, a professor of diabetes at the University of Michigan and president of medicine and science at the American Diabetes Association. “In the U.S. alone there are 37 million...
Source: TIME: Health - December 29, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate Source Type: news

Even a Little Less Carb Intake Can Help Folks With Type 1 Diabetes
WEDNESDAY, Dec. 27, 2023 -- It may not take as strict a diet as thought to keep type 1 diabetes under control: New Swedish research shows that a moderate low-carb diet still helped people with type 1 diabetes stick to blood-sugar targets. " The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 27, 2023 Category: General Medicine Source Type: news

The Most Exciting New Advancements in Managing and Treating Lupus
The case study involved just one patient: a 20-year-old woman with severe systemic lupus erythematosus (SLE). But the study’s results were so dramatic that they appeared in 2021 in the New England Journal of Medicine.  The woman received a type of cell therapy called CAR-T, which in the past has been used primarily to treat cancer. CAR-T cell therapy involves altering a patient’s immune cells so that they identify and attack problems or pathogens. In people with cancer, that attack is aimed at the diseased cells. But in the NEJM case study, the therapy was directed at the woman’s own B cells,...
Source: TIME: Health - December 27, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate Source Type: news

Outpatient screening for anxiety and depression symptoms in adolescents with type 1 diabetes - a cross-sectional survey - Reinauer C, Tittel SR, M üller-Stierlin A, Baumeister H, Warschburger P, Klauser K, Minden K, Staab D, Gohlke B, Horlebein B, Schwab KO, Meißner T, Holl RW.
BACKGROUND: The daily demands of type 1 diabetes management may jeopardize adolescents' mental health. We aimed to assess anxiety and depression symptoms by broad-scale, tablet-based outpatient screening in adolescents with type 1 diabetes in Germany. ... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Diabetes type 1 technology gets green light from NICE and NHS
The NHS in England and Wales has agreed to develop plans to make hybrid closed-loop technology available for eligible people with type 1 diabetes. The news follows the publishing of National Institute of Health Care and Excellence (NICE) recommendations for the technology’s use – a development welcomed as a ‘landmark’ by charity Diabetes UK. NICE... Read moreThe post Diabetes type 1 technology gets green light from NICE and NHS appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - December 20, 2023 Category: Nursing Authors: Megan Ford Tags: Clinical Diabetes Latest news Source Type: news

" We Will Rock You " Into Real-time Diabetes Control " We Will Rock You " Into Real-time Diabetes Control
Rock music could offer patients with type 1 diabetes the means to stimulate insulin release and achieve real-time diabetes control via adapted pancreatic cells and speakers, suggests a novel study.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 15, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

' We Will Rock You' Into Real-time Diabetes Control'We Will Rock You' Into Real-time Diabetes Control
Rock music could offer patients with type 1 diabetes the means to stimulate insulin release and achieve real-time diabetes control via adapted pancreatic cells and speakers, suggests a novel study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 15, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology Source Type: news

Stem Cell Therapy Implant Shows Promise for Type 1 Diabetes Stem Cell Therapy Implant Shows Promise for Type 1 Diabetes
An experimental device containing millions of stem cells significantly reduced the need for insulin shots among people with type 1 diabetes.WebMD Health News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 12, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news

Stem Cell Therapy Implant Shows Promise For Type 1 Diabetes
Researchers say the treatment may someday provide a cure for the chronic, life-altering condition. (Source: WebMD Health)
Source: WebMD Health - December 11, 2023 Category: Consumer Health News Source Type: news

Thousands of kidney disease patients set to benefit from £1-a-dose diabetes drug which can reduce the need for dialysis and a transplant
Kidney disease is usually triggered by the damage caused by another illness, such as type 1 and type 2 diabetes or high blood pressure. (Source: the Mail online | Health)
Source: the Mail online | Health - December 9, 2023 Category: Consumer Health News Source Type: news

Sweet and Sour: A Patient ’s Perspective on Type 1 Diabetes and Mental Health Sweet and Sour: A Patient ’s Perspective on Type 1 Diabetes and Mental Health
Are you aware of the daily and long-term challenges for the mental health of young adults living with type 1 diabetes (T1D)?Medscape Education Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 8, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Review Source Type: news

Daily Baricitinib Treatment Preserves β-Cell Function in Type 1 Diabetes
THURSDAY, Dec. 7, 2023 -- Daily baricitinib treatment over 48 weeks preservesβ-cell function in patients with type 1 diabetes diagnosed recently, according to a study published in the Dec. 7 issue of the New England Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 7, 2023 Category: Pharmaceuticals Source Type: news

Rheumatoid Arthritis Drug Could Put Brakes on Type 1 Diabetes
THURSDAY, Dec. 7, 2023 -- A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes.Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2023 Category: General Medicine Source Type: news

Rheumatoid Arthritis Drug, Baricitinib (Olumiant), Could Put Brakes on Type 1 Diabetes
THURSDAY, Dec. 7, 2023 -- A drug long used to curb rheumatoid arthritis may be a potent foe against another immune disorder, type 1 diabetes. Australian researchers report that baricitinib (Olumiant) appears to help patients newly diagnosed with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2023 Category: General Medicine Source Type: news

JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes
(MedPage Today) -- A Janus kinase (JAK) inhibitor helped preserve beta-cell function in people with recent-onset type 1 diabetes, the phase II BANDIT trial found. Meeting the study's primary endpoint, daily baricitinib (Olumiant) maintained a... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 7, 2023 Category: Cardiology Source Type: news